Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA

Cancer Research

Volumn 64, Issue 14, 2004, Pages 4833-4840

  Li, Shang ^a   Rosenberg, Jonathan E ^a   Donjacour, Annemarie A ^a   Botchkina, Inna L ^a   Hom, Yun Kit ^a   Cunha, Gerald R ^a   Blackburn, Elizabeth H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT TEMPLATE TELOMERASE RNA; PROTEIN P53; RIBONUCLEOPROTEIN; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL KILLING; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LENTIVIRINAE; MALE; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; TELOMERE; TUMOR GROWTH; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ANIMALS; APOPTOSIS; CELL DIVISION; GENE THERAPY; HUMANS; LENTIVIRUS; MALE; MICE; MICE, NUDE; RATS; RNA; RNA, SMALL INTERFERING; TELOMERASE; TELOMERE; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 3142661809     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0953     Document Type: Article

References (43)

1. Blackburn EH. Telomere states and cell fates. Nature (Lond) 2000;408:53-6.
2. Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985;43:405-13.
3. Yu GL, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs, Nature (Lond) 1990;344:126-32.
4. Ijpma AS, Greider CW. Short telomeres induce a DNA damage response in Saccharomyces cerevisiae. Mol Biol Cell 2003;14:987-1001.
5. Enomoto S, Glowczewski L, Berman J. MEC3, MEC1, and DDC2 are essential components of a telomere checkpoint pathway required for cell cycle arrest during senescence in Saccharomyces cerevisiae. Mol Biol Cell 2002;13:2626-38.
6. Nautiyal S, DeRisi JL, Blackburn EH. The genome-wide expression response to telomerase deletion in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2002;99: 9316-21.
7. Lendvay TS, Morris DK, Sah J, Balasubramanian B, Lundblad V. Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 1996;144:1399-412.
8. Cohn M, Blackburn EH, Telomerase in yeast. Science (Wash DC) 1995;269:396-400.
9. Singer MS, Gottschling DE. TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science (Wash DC) 1994;266:404-9.
10. Rudolph KL, Chang S, Lee HW, et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999;96:701-12.
11. Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature (Lond) 2001;413: 432-5.
12. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science (Wash DC) 1995;269:1236-41.
13. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science (Wash DC) 1997;277:955-9.
14. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash DC) 1994;266:2011-5.
15. Wright WE, Piatyszek MA, Rainey WE, et al. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996;18:173-9.
16. Masutomi K, Yu EY, Khurts S, et al. Telomerase maintains telomere structure in normal human cells. Cell 2003;114:241-53.
17. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-91.
18. Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol 2003;5:474-9.
19. Chang S, Khoo CM, Naylor ML, et al. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 2003;17: 88-100.
20. Guiducci C, Cerone MA, Bacchetti S. Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene 2001;20:714-25.
21. Kim MM, Rivera MA, Botchkina IL, et al. A low threshold level of expression of mutant-template telomerase RNA is sufficient to inhibit human tumor cell growth. Proc Natl Acad Sci USA 2001;98:7982-7.
22. Marusic L, Anton M, Tidy A, et al. Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol Cell Biol 1997;17:6394-401.
23. Gilley D, Lee MS, Blackburn EH. Altering specific telomerase RNA template residues affects active site function, Genes Dev 1995;9:2214-26.
24. Kirk KE, Harmon BP, Reichardt IK, Sedat JW, Blackburn EH. Block in anaphase chromosome separation caused by a telomerase template mutation. Science (Wash DC) 1997;275:1478-81.
25. McEachern MJ, Blackburn EH, Runaway telomere elongation caused by telomerase RNA gene mutations. Nature (Lond) 1995;376:403-9.
26. Smith CD, Blackburn EH. Uncapping and deregulation of telomeres lead to detrimental cellular consequences in yeast. J Cell Biol 1999;145:203-14.
27. Conrad MN, Wright JH, Wolf AJ, Zakian VA. RAP1 protein interacts with yeast telomeres in vivo: overproduction alters telomere structure and decreases chromosome stability. Cell 1990;63:739-50.
28. Longtine MS, Wilson NM, Petracek ME, Berman J. A yeast telomere binding activity binds to two related telomere sequence motifs and is indistinguishable from RAPI. Curr Genet 1989;16:225-39.
29. Lustig AJ, Kurtz S, Shore D. Involvement of the silencer and UAS binding protein RAP1 in regulation of telomere length. Science (Wash DC) 1990;250:549-53.
30. Nugent CI, Hughes TR, Lue NF, Lundblad V. Cdc13p: a single-strand telomeric DNA-binding protein with a dual role in yeast telomere maintenance. Science (Wash DC) 1996;274:249-52.
31. Baumann P, Cech TR. Potl, the putative telomere end-binding protein in fission yeast and humans. Science (Wash DC) 2001;292:1171-5.
32. Fairall L, Chapman L, Moss H, de Lange T, Rhodes D. Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2. Mol Cell 2001;8:351-61.
33. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science (Wash DC) 1999;283:1321-5.
34. Smogorzewska A, de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J 2002;21:4338-48.
35. Yi X, Tesmer VM, Savre-Train I, Shay JW, Wright WE. Both transcriptional and posttranscriptional mechanisms regulate human telomerase template RNA levels. Mol Cell Biol 1999;19:3989-97.
36. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science (Wash DC) 2002;296:550-3.
37. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond) 2001;411: 494-8.
38. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (Wash DC) 1996;272:263-7.
39. Bertrand E, Castanotto D, Zhou C, et al. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 1997;3:75-88.
40. Tissue culture in medical research. Oxford, United Kingdom: Pergamon Press; 1980. p. 213-20.
41. Assessment of current concepts and approaches to the study of prostate cancer. New York: Liss, A. R.; 1987. p. 273-82.
42. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997;3:1271-4.
43. Gonzalez-Suarez E, Samper E, Ramirez A, et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 2001;20:2619-30.